(Q37907386)

25 August 2017

1 reference

title

Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

Athina Vadalouca

1

1 reference

25 August 2017

Efklidis Raptis

2

1 reference

25 August 2017

Eleni Moka

3

1 reference

25 August 2017

Panagiotis Zis

4

1 reference

25 August 2017

Panagiota Sykioti

5

1 reference

25 August 2017

Ioanna Siafaka

6

1 reference

25 August 2017

publication date

29 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

12

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

219-251

1 reference

Mechanism-based pain diagnosis: issues for analgesic drug development

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Ion channels of nociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pain genes?: natural variation and transgenic mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Towards a mechanism-based classification of pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A comparison of pain and health-related quality of life between two groups of cancer patients with differing average levels of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Prevalence and impact of depression and pain in neurology outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Assessment and treatment of neuropathic cancer pain following WHO guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Molecular mechanisms of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

21 January 2018

The neurobiology of pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Opioids and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Diagnosis and Treatment of Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

EFNS guidelines on neuropathic pain assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neuropathic pain: clinical characteristics and diagnostic workup

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Peripheral neuropathic pain--a multidimensional burden for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neurogenic pain syndromes and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Incidence of central post-stroke pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neuropathic pain and its assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Malignant bone pain: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Breakthrough pain in cancer patients: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Breakthrough pain: characteristics and impact in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Peripheral neuropathy and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Cancer pain and analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The Amsterdam Pain Management Index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Cancer pain and its impact on diagnosis, survival and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Radiation-induced brachial plexus neuropathy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Translational medicine: cancer pain mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The clinical course of bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Bone metastases and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Treatment outcome in a multidisciplinary cancer pain clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Challenges in cancer pain management--bone pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Chemotherapy-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Therapy of chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Cellular and neurochemical remodeling of the spinal cord in bone cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The management of intractable bone pain: a clinician's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Descending modulation of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Contemporary assessment and management of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Laser-evoked potentials as a tool for assessing the efficacy of antinociceptive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Evidence-based pharmacological treatment of neuropathic pain syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pain and dysesthesia in patients with spinal cord injury: A postal survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Management of painful diabetic neuropathy. A treatment algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

21 January 2018

Trigeminal Neuralgia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A treatment algorithm for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Effectiveness of tizanidine in neuropathic pain: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A validation study of the WHO method for cancer pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Management of cancer pain: basic principles and neuropathic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Investigation of an opioid response categorization in advanced cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Recent advances in the pharmacological management of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Principles of control of cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Adjuvant agents in cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Mechanistic Stratification of Antineuralgic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Venlafaxine in neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin acts within the locus coeruleus to alleviate neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for the treatment of pain in guillain-barré syndrome: a double-blinded, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin significantly improves analgesia in people receiving opioids for neuropathic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for relief of neuropathic pain related to anticancer treatment: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Differences in gabapentin efficacy for cancer pain more apparent than real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for pain control in cancer patients' wound dressing care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The use of gabapentin in a 12-year-old boy with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for opiod-related myoclonus in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for coeliac plexus pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Strategies for the treatment of cancer pain in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin: resistant neuropathic pain and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Management of neuropathic cancer pain following WHO analgesic ladder: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Analysis and treatment of different types of neuropathic cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Gabapentin for the treatment of cancer-related pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Evidence-based approaches to pain in advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Intrathecal gabapentin and clonidine synergistically inhibit allodynia in spinal nerve-ligated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Single dose oral nabumetone for acute postoperative pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Lamotrigine in spinal cord injury pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Efficacy of pregabalin in neuropathic pain in paediatric oncological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Tramadol as an analgesic for mild to moderate cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The effect of opioids on phantom limb pain and cortical reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Oral opioid therapy for chronic peripheral and central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Opioids in pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Spinal cord pharmacology of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Opioid rotation in the management of refractory cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neuropathic pain - the case for opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Oxycodone/paracetamol: a low-dose synergic combination useful in different types of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Oral morphine for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Opioid Therapy for Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

NSAIDS or paracetamol, alone or combined with opioids, for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Topical capsaicin in the management of HIV-associated peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Parenteral lidocaine for severe intractable pain in six hospice patients continued at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Comparison of morphine and morphine with ketamine for postoperative analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Managing metastatic bone pain: the role of bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Bisphosphonates for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Bisphosphonates for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The Therapeutic Uses of Calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Pain killing with calcitonin nasal spray in patients with malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Calcitonin for metastatic bone pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Using cannabinoids in pain and palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Tapentadol immediate-release for acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

The evidence for pharmacological treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00485.X

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001133.PUB2

Gabapentin for acute and chronic pain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD005452

Identifiers

DOI

10.1111/J.1533-2500.2011.00485.X

1 reference

25 August 2017

1 reference